In a multicenter, randomized, investigator-blind, parallel study, 398 patients were dispensed topical butoconazole nitrate 2% cream for 3 days (n 199) 
fective intravaginal antifungal agents to treat vulvovaginal candidiasis, one of the most common gynecological problems. 1,e It is important for women who are first-time sufferers to consult their physicians before using any over-the-counter products to encourage compliance may include short-term antifungal therapy. 3, 4 The primary objective of this study was to compare the effectiveness and safety of 3-day butoconazole with 7- range 51-72 in.). There were significant differences between the treatment groups in systolic blood pressure (P 0.06), and there were significant treatment-by-investigator interactions for weight (P 0.003), systolic blood pressure (P 0.098), and diastolic blood pressure (P 0.053). These variables were not considered to have an impact on the cure rate outcomes. The groups were comparable in baseline (pretreatment) signs of erythema, ulceration, and presence and quantity of discharge. There were significant differences between the groups in baseline vulvovaginal burning (P 0.004) and itching (P 0.078), with 
